4/11
01:00 am
bctx
Low
Report
3/31
04:22 pm
bctx
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License [Yahoo! Finance]
Low
Report
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License [Yahoo! Finance]
3/31
04:12 pm
bctx
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License [TheStreet.com]
Low
Report
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License [TheStreet.com]
3/31
04:05 pm
bctx
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License
Low
Report
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License
3/18
08:13 am
bctx
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference [Yahoo! Finance]
Medium
Report
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference [Yahoo! Finance]
3/18
07:30 am
bctx
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference
Medium
Report
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference
3/10
08:04 am
bctx
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting [Yahoo! Finance]
Low
Report
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting [Yahoo! Finance]
3/10
07:30 am
bctx
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
Low
Report
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
3/5
05:28 pm
bctx
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting [Canadian Business Journal (Canada)]
Medium
Report
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting [Canadian Business Journal (Canada)]
3/5
04:04 pm
bctx
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
Medium
Report
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
2/18
05:30 pm
bctx
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
Neutral
Report
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
2/17
07:30 am
bctx
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
Medium
Report
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
1/28
07:47 am
bctx
BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation [Yahoo! Finance]
Medium
Report
BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation [Yahoo! Finance]
1/28
07:30 am
bctx
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
Medium
Report
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
1/27
07:30 am
bctx
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
Low
Report
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients